Literature DB >> 3927718

Elimination kinetics of blood lead in workers with chronic lead intoxication.

D O Hryhorczuk, M B Rabinowitz, S M Hessl, D Hoffman, M M Hogan, K Mallin, H Finch, P Orris, E Berman.   

Abstract

Blood lead elimination half-lives were determined for 65 patients with occupational chronic lead intoxication who were removed from exposure, treated with intravenous EDTA, and followed for periods of up to 2,419 days. The median overall blood lead elimination half-life was 619 days in patients with normal renal function and 1,907 days in patients with renal impairment. Slow-phase elimination half-lives in patients followed for longer than 5 years ranged from 1,658 to 7,189 days. Blood lead concentrations declined during periods of chelation with a mean half-life of 7 days and rebounded to near prechelation concentrations following termination of chelation with a mean doubling time of 27 days. The overall blood lead elimination half-life was positively associated with length of follow-up (p less than 0.001), age (p = 0.04), and duration of exposure (p = 0.02), but was not associated with the initial blood lead concentration following cessation of exposure or the total amount of EDTA received.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3927718     DOI: 10.1002/ajim.4700080105

Source DB:  PubMed          Journal:  Am J Ind Med        ISSN: 0271-3586            Impact factor:   2.214


  11 in total

1.  A longitudinal study of the relation of lead in blood to lead in air concentrations among battery workers.

Authors:  D G Hodgkins; T G Robins; D L Hinkamp; M A Schork; W H Krebs
Journal:  Br J Ind Med       Date:  1992-04

Review 2.  Mechanisms of lead-induced hypertension and cardiovascular disease.

Authors:  Nosratola D Vaziri
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-20       Impact factor: 4.733

3.  Chelation therapy in workers with lead exposure.

Authors:  S Royce; J Rosenberg
Journal:  West J Med       Date:  1993-04

4.  Lead exchange in teeth and bone--a pilot study using stable lead isotopes.

Authors:  B L Gulson; B R Gillings
Journal:  Environ Health Perspect       Date:  1997-08       Impact factor: 9.031

Review 5.  Chronic low-level lead exposure. Its role in the pathogenesis of hypertension.

Authors:  D S Sharp; C E Becker; A H Smith
Journal:  Med Toxicol       Date:  1987 May-Jun

6.  2,3-Dimercaptosuccinic acid treatment of heavy metal poisoning in humans.

Authors:  L Fournier; G Thomas; R Garnier; A Buisine; P Houze; F Pradier; S Dally
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Nov-Dec

7.  Comparison of measures of lead exposure, dose, and chelatable lead burden after provocative chelation in organolead workers.

Authors:  B S Schwartz; M P McGrail; W Stewart; T Pluth
Journal:  Occup Environ Med       Date:  1994-10       Impact factor: 4.402

Review 8.  Toxicokinetics of bone lead.

Authors:  M B Rabinowitz
Journal:  Environ Health Perspect       Date:  1991-02       Impact factor: 9.031

Review 9.  Historical perspective on lead biokinetic models.

Authors:  M Rabinowitz
Journal:  Environ Health Perspect       Date:  1998-12       Impact factor: 9.031

10.  Skeletal Lead Burden of the British Royal Navy in Colonial Antigua.

Authors:  K L Giffin; T Swanston; I Coulthard; A R Murphy; D M L Cooper; T L Varney
Journal:  Int J Osteoarchaeol       Date:  2017-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.